DXCM Live signaler | Maksimer profitt med Getagraph.com

KJøP 4417 min ago

@ $137.94

Utstedt: 25 apr 2024 @ 21:42

Avkastning: -9.86%

Forrige signal: apr 25 - 18:41

Forrige signal: Selg

Avkastning: 0.81 %

Live Chart Being Loaded With Signals

Commentary (26 apr 2024 @ 22:00):

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally...

Stats
Dagens volum	8.55M
Gjennomsnittsvolum	3.17M
Markedsverdi	49.24B
EPS	$0 ( 2024-04-25 )
Neste inntjeningsdato	( $0.390 ) 2024-07-25
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	95.65
ATR14	$13.59 (10.93%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-15	Dolan Matthew Vincent	Sell	1 990	Common Stock
2024-04-08	Sayer Kevin R	Sell	27 272	Common Stock
2024-04-08	Sayer Kevin R	Sell	22 361	Common Stock
2024-03-28	Brown Michael Jon	Sell	2 524	Common Stock
2024-03-28	Brown Michael Jon	Sell	100	Common Stock

INSIDER POWER
-3.99
Last 99 transactions
Buy: 330 077 \| Sell: 354 468

Volum Korrelasjon

Lang: -0.86 (strong negative)

Kort: -0.83 (strong negative)

Signal:(37) Neutral

DexCom Inc Korrelasjon

10 Mest positive korrelasjoner
SVBI	0.821
BOSC	0.807

10 Mest negative korrelasjoner
QTEK	-0.802

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

DexCom Inc Korrelasjon - Valuta/Råvare

0.34
( neutral )

0.54
( weak )

0.00
( neutral )

0.62
( weak )

-0.34
( neutral )

-0.47
( neutral )

DexCom Inc Økonomi

Annual	2023
Omsetning:	$3.62B
Bruttogevinst:	$2.29B (63.19 %)
EPS:	$1.400

FY	2023
Omsetning:	$3.62B
Bruttogevinst:	$2.29B (63.19 %)
EPS:	$1.400

FY	2022
Omsetning:	$2.91B
Bruttogevinst:	$1.88B (64.72 %)
EPS:	$0.880

FY	2021
Omsetning:	$2.45B
Bruttogevinst:	$1.68B (68.63 %)
EPS:	$0.400

Financial Reports:

No articles found.

DexCom Inc

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.